首页> 外文期刊>Advances in Interventional Cardiology: Postepy w Kardiologii Interwencyjnej >Five-year outcomes after revascularization of superficial femoral artery occlusion using Ocelot catheter
【24h】

Five-year outcomes after revascularization of superficial femoral artery occlusion using Ocelot catheter

机译:使用Ocelot导管对股浅动脉进行血运重建后的五年结果

获取原文
           

摘要

Introduction The population of patients with lower limb atherosclerosis includes a considerable proportion of individuals with long superficial femoral artery (SFA) lesions. Chronic total occlusions (CTOs) represent the “last frontier” of percutaneous interventions. While open strategies are considered earlier as standard management for these lesions, the results of a number of trials indicate that endovascular management might become an effective alternative to surgery. Material and methods This paper presents 5-year outcomes of a first-in-man (FIM) study (before CE mark) and the registry of OCT Guided Ocelot Catheter (Avinger) for chronic total occlusions of the superficial femoral artery. The study group comprised 10 patients with Rutherford 3 lower limb ischemia including nine men and one woman. Results The efficacy of the primary intervention was 90%. Angiography performed at 6 months of the procedure, according to the study protocol, revealed 3 and 1 cases of restenosis and reocclusion, respectively, repaired using PTA and open common and deep femoral artery patch plasty. Doppler ultrasound performed at 1, 2 and 5 years after the primary intervention did not reveal significant target vessel restenosis. The primary and primary-assisted patency was 89%. During a 5-year follow-up, four peripheral percutaneous interventions and one femoropopliteal bypass surgery were performed in non-target limbs. There were no cardiovascular deaths, myocardial infarction or stroke and no amputation was required. Conclusions This is a first-in-man study reporting long-term follow-up after SFA CTO revascularization using the Ocelot catheter. The catheter proved to have a satisfactory safety profile and a high proportion of CTO crossings. A 5-year follow-up revealed high primary and primary-assisted patency rates.
机译:简介下肢动脉粥样硬化的患者人群包括相当一部分患有股浅表动脉长(SFA)病变的个体。慢性完全阻塞(CTO)代表了经皮干预的“最后前沿”。尽管开放策略在早期被认为是这些病变的标准治疗方法,但许多试验的结果表明,血管内治疗可能成为手术的有效替代方法。材料和方法本文介绍了一项首次人(FIM)研究(在CE标志之前)的5年结果以及OCT引导的Ocelot导尿管(Avinger)用于慢性股浅动脉总闭塞的注册资料。该研究组包括10名卢瑟福3下肢缺血的患者,其中9名男性和1名女性。结果一次干预的有效率为90%。根据研究方案,在术后6个月进行血管造影检查,分别发现3例和1例再狭窄和再闭塞,分别通过PTA修补和开放性股总动脉和深股动脉修补术修复。在主要干预后1、2和5年进行的多普勒超声检查未发现明显的靶血管再狭窄。初级和初级辅助通畅率为89%。在为期5年的随访中,对非目标肢体进行了四次外周经皮干预和一项股pop旁路手术。没有心血管死亡,心肌梗塞或中风,也不需要截肢。结论这是一项首次人体研究,报告了使用Ocelot导管进行SFA CTO血管重建后的长期随访。事实证明,该导管具有令人满意的安全性和较高的CTO穿越率。进行了5年的随访,发现初次和初次辅助通畅率较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号